Loading company…
Muna Therapeutics discovers and develops treatments for neurodegenerative diseases.
Muna Therapeutics discovers and develops therapies for neurodegenerative diseases, including Alzheimer's, Frontotemporal Dementia, and Parkinson's. Founded in 2020 and based in Copenhagen, Denmark, it raised DKK 450 million in Series A funding in July 2021, co-led by DROIA Ventures, Life Sciences Partners, Novo Holdings, and Sofinnova Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in